Genetic Characterization and Prognostic Relevance of Acquired Uniparental Disomies in Cytogenetically Normal Acute Myeloid Leukemia

被引:18
|
作者
Walker, Christopher J. [1 ]
Kohlschmidt, Jessica [1 ,2 ]
Eisfeld, Ann-Kathrin [1 ]
Mrozek, Krzysztof [1 ]
Liyanarachchi, Sandya [1 ]
Song, Chi [3 ]
Nicolet, Deedra [1 ,2 ]
Blachly, James S. [1 ]
Bill, Marius [1 ]
Papaioannou, Dimitrios [1 ]
Oakes, Christopher C. [1 ]
Giacopelli, Brian [1 ]
Genutis, Luke K. [1 ]
Maharry, Sophia E. [1 ]
Orwick, Shelley [1 ]
Archer, Kellie J. [1 ,3 ]
Powell, Bayard L. [4 ]
Kolitz, Jonathan E. [5 ]
Uy, Geoffrey L. [6 ]
Wang, Eunice S. [7 ]
Carroll, Andrew J. [8 ]
Stone, Richard M. [9 ]
Byrd, John C. [1 ]
de la Chapelle, Albert [1 ]
Bloomfield, Clara D. [1 ]
机构
[1] Ohio State Univ, Ctr Comprehens Canc, Biomed Res Tower,Room 894,460 W 12th Ave, Columbus, OH 43210 USA
[2] Ohio State Univ, Ctr Comprehens Canc, Alliance Stat & Data Ctr, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Publ Hlth, Div Biostat, Columbus, OH 43210 USA
[4] Wake Forest Baptist Comprehens Canc Ctr, Winston Salem, NC USA
[5] Zucker Sch Med Hofstra Northwell, Monter Canc Ctr, Lake Success, NY USA
[6] Washington Univ, Sch Med St Louis, Siteman Canc Ctr, St Louis, MO 63110 USA
[7] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA
[8] Univ Alabama Birmingham, Birmingham, AL USA
[9] Dana Farber Canc Inst, Boston, MA 02115 USA
关键词
GROUP-B; DOSE CYTARABINE; CEBPA MUTATIONS; AGE; 60; CANCER; ADULTS; IMPACT; AML; CHEMOTHERAPY; NUMBER;
D O I
10.1158/1078-0432.CCR-19-0725
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Uniparental disomy (UPD) is a way cancer cells duplicate a mutated gene, causing loss of heterozygosity (LOH). Patients with cytogenetically normal acute myeloid leukemia (CN-AML) do not have microscopically detectable chromosome abnormalities, but can harbor UPDs. We examined the prognostic significance of UPDs and frequency of LOH in patients with CN-AML. Experimental Design: We examined the frequency and prognostic significance of UPDs in a set of 425 adult patients with de novo CN-AML who were previously sequenced for 81 genes typically mutated in cancer. Associations of UPDs with outcome were analyzed in the 315 patients with CN-AML younger than 60 years. Results: We detected 127 UPDs in 109 patients. Most UPDs were large and typically encompassed all or most of the affected chromosome arm. The most common UPDs occurred on chromosome arms 13q (7.5% of patients), 6p (2.8%), and 11p (2.8%). Many UPDs significantly cooccurred with mutations in genes they encompassed, including 13q UPD with FLT3-internal tandem duplication (FLT3-ITD; P < 0.001), and 11p UPD with WT1 mutations (P = 0.02). Among patients younger than 60 years, UPD of 11p was associated with longer overall survival (OS) and 13q UPD with shorter disease-free survival (DFS) and OS. In multivariable models that accounted for known prognostic markers, including FLT3-ITD and WT1 mutations, UPD of 13q maintained association with shorter DFS, and UPD of 11p maintained association with longer OS. Conclusions: LOH mediated by UPD is a recurrent feature of CN-AML. Detection of UPDs of 13q and 11p might be useful for genetic risk stratification of patients with CN-AML.
引用
收藏
页码:6524 / 6531
页数:8
相关论文
共 50 条
  • [41] Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia
    Griffiths, Elizabeth A.
    Gore, Steven D.
    Hooker, Craig M.
    Mohammad, Helai P.
    McDevitt, Michael A.
    Smith, B. Douglas
    Karp, Judith E.
    Herman, James G.
    Carraway, Hetty E.
    EPIGENETICS, 2010, 5 (07) : 590 - 600
  • [42] Molecular profiling of patients with cytogenetically normal acute myeloid leukemia and hyperleukocytosis
    Pastore, Friederike
    Pastore, Alessandro
    Rothenberg-Thurley, Maja
    Metzeler, Klaus H.
    Ksienzyk, Bianka
    Schneider, Stephanie
    Bohlander, Stefan K.
    Braess, Jan
    Sauerland, Maria C.
    Goerlich, Dennis
    Berdel, Wolfgang E.
    Woermann, Bernhard
    Von Bergwelt-Baildon, Michael S.
    Hiddemann, Wolfgang
    Spiekermann, Karsten
    CANCER, 2022, 128 (24) : 4213 - 4222
  • [43] Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia
    Reuter, Christoph W. M.
    Krauter, Juergen
    Onono, Fredrick O.
    Bunke, Tania
    Damm, Frederik
    Thol, Felicitas
    Wagner, Katharina
    Goehring, Gudrun
    Schlegelberger, Brigitte
    Heuser, Michael
    Ganser, Arnold
    Morgan, Michael A.
    ANNALS OF HEMATOLOGY, 2014, 93 (06) : 977 - 982
  • [44] Immunity In Cytogenetically Normal Acute Myeloid Leukemia (iCN-AML)
    Ting, Stephen
    Lee, Denise
    Low, Michael
    Ling, Yee-May
    Trung Nguyen
    McQuilten, Zoe K.
    Cody, Stephen
    McLean, Catriona
    BLOOD, 2013, 122 (21)
  • [45] Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
    Renneville, A.
    Boissel, N.
    Nibourel, O.
    Berthon, C.
    Helevaut, N.
    Gardin, C.
    Cayuela, J-M
    Hayette, S.
    Reman, O.
    Contentin, N.
    Bordessoule, D.
    Pautas, C.
    de Botton, S.
    de Revel, T.
    Terre, C.
    Fenaux, P.
    Thomas, X.
    Castaigne, S.
    Dombret, H.
    Preudhomme, C.
    LEUKEMIA, 2012, 26 (06) : 1247 - 1254
  • [46] Molecular stratification model for prognosis in cytogenetically normal acute myeloid leukemia
    Santamaria, Carlos M.
    Chillon, Maria C.
    Garcia-Sanz, Ramon
    Perez, Cristina
    Caballero, Maria D.
    Ramos, Fernando
    Garcia de Coca, Alfonso
    Alonso, Jose M.
    Giraldo, Pilar
    Bernal, Teresa
    Queizan, Jose A.
    Rodriguez, Juan N.
    Fernandez-Abellan, Pascual
    Barez, Abelardo
    Penarrubia, Maria J.
    Balanzategui, Ana
    Vidriales, Maria B.
    Sarasquete, Maria E.
    Alcoceba, Miguel
    Diaz-Mediavilla, Joaquin
    San Miguel, Jesus F.
    Gonzalez, Marcos
    BLOOD, 2009, 114 (01) : 148 - 152
  • [47] Prognostic Significance of DNA Methyltransferase 3A Mutations in Cytogenetically Normal Acute Myeloid Leukemia: A Study by the Acute Leukemia French Association
    Renneville, Aline
    Boissel, Nicolas
    Nibourel, Olivier
    Berthon, Celine
    Helevaut, Nathalie
    Gardin, Claude
    Cayuela, Jean-Michel
    Hayette, Sandrine
    Reman, Oumedaly
    Contentin, Nathalie
    Bordessoule, Dominique
    Pautas, Cecile
    de Botton, Stephane
    De Revel, Thierry
    Terre, Christine
    Fenaux, Pierre
    Thomas, Xavier
    Castaigne, Sylvie
    Dombret, Herve
    Preudhomme, Claude
    BLOOD, 2011, 118 (21) : 1072 - 1073
  • [48] Prognostically Important Molecular Markers in Cytogenetically Normal Acute Myeloid Leukemia
    Lin, Tara L.
    Smith, B. Douglas
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2011, 341 (05): : 404 - 408
  • [49] Prognostic significance of DNA methyltransferase 3A mutations in cytogenetically normal acute myeloid leukemia: a study by the Acute Leukemia French Association
    A Renneville
    N Boissel
    O Nibourel
    C Berthon
    N Helevaut
    C Gardin
    J-M Cayuela
    S Hayette
    O Reman
    N Contentin
    D Bordessoule
    C Pautas
    S de Botton
    T de Revel
    C Terre
    P Fenaux
    X Thomas
    S Castaigne
    H Dombret
    C Preudhomme
    Leukemia, 2012, 26 : 1247 - 1254
  • [50] Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia
    Christoph W. M. Reuter
    Jürgen Krauter
    Fredrick O. Onono
    Tania Bunke
    Frederik Damm
    Felicitas Thol
    Katharina Wagner
    Gudrun Göhring
    Brigitte Schlegelberger
    Michael Heuser
    Arnold Ganser
    Michael A. Morgan
    Annals of Hematology, 2014, 93 : 977 - 982